News releases | Medicago

Medicago

Menu
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • fr
  • News releases

News releases

  • All
  • Antibodies 1
  • Corpo 8
  • Vaccine 19
  • Clinical trials 7
  • COVID-19 17
    • Antibodies
    October 29, 2015

    Medicago engaged by the Canadian government to develop Ebola monoclonal antibodies

    Press release Medicago 2015-2017
    Read more
Medicago
  • Media
  • Careers
  • Culture
  • FAQ
  • Contact
  • Our company
    Our company
    • Our history
    • Our mission and values
    • Our commitment to ethics
    • Our pandemic response
    • Our leadership team
    • Our locations
    • Our partners
  • Our science
    Our science
    • Your health
    • Our R&D pipeline
    • Our clinical trials
    • Our vaccine candidates
    • Our therapeutic antibody research
  • Our technologies
    Our technologies
    • Plant-based technology
    • Our technology illustrated
    • Virus-like particles
  • Our vaccines
    Our vaccines
    • Covifenz
    • Reporting side effects
  • Legal
  • Privacy
  • Community guideline
  • Cookie policy
© Medicago Inc, 2022

This website uses cookies. Find out more

You are leaving a Medicago website

Medicago does not review or control the content of non-Medicago websites, and this link does not constitute an endorsement by Medicago of that site’s content.